News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Multiply Labs and GenScript Biotech Corporation Join Forces to Automate Cell Isolation and Enrichment in Cell Therapy Manufacturing
Wednesday, April 24, 2024GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase
AVEROA Applies to European Medicines Agency for Approval of AVA1014 in Treating Complications Linked to Chronic Kidney Disease
Wednesday, April 24, 2024Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines
Regeneration Biomedical Initiates First Patient in Phase I Clinical Trial Administering Stem Cell Therapy Directly into Alzheimer’s Patients’ Brains
Wednesday, April 24, 2024Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase
Ochre Biomedicine and Bailingjia Ingelheim Collaborate on Innovative Treatments for Advanced Liver Disease
Tuesday, April 23, 2024Ochre Bio a pioneer in the realm of drug development for chronic liver ailments has forged a partnership with Boehringer Ingelheim a prominent German pharmaceutical company Their joint efforts
Hyundai Bioscience's Preclinical Study Shows Success with Niclosamide-based Oral Anticancer Treatment for Triple-Negative Breast Cancer
Monday, April 22, 2024Hyundai Bioscience has announced positive results from its preclinical study on triplenegative breast cancer The study investigated a combination therapy of a Niclosamidebased oral anticancer drug
Cognivia Secures €15.5 Million in Strategic Funding for AI and ML-Driven Drug Development
Saturday, April 20, 2024Cognivia an innovative AI company revolutionizing pharmaceutical and biotech clinical research with cuttingedge AIML algorithms proudly announces a significant investment milestone Vesalius Biocapital
D2M Biotherapeutics Initiates Phase 1 Study of DM919, a Novel MICA/B Antibody for Advanced Solid Tumors, with First Patient Dosed
Friday, April 19, 2024DM Biotherapeutics Inc a clinicalstage biotech company announced today that it has initiated dosing the first patient in a phase study of DM DM is a novel monoclonal antibody targeting MICAB
Panasonic and Shinobi Therapeutics Collaborate on Cost-Effective iPS Cell Therapy Manufacturing Technology
Friday, April 19, 2024Shinobi Therapeutics a biotech firm pioneering a new line of immuneevasive iPS cell therapies has forged a collaboration with Panasonic Holdings Corp and Kyoto Universitys Center for iPS
X-Therma Receives FDA Approval for XT-Thrive® Drug Master File
Thursday, April 18, 2024XTherma Inc a pioneering biotechnology firm specializing in regenerative medicine and organ preservation has reached a significant milestone with the Food and Drug Administration accepting its Drug Master File for XTThrive This DMF encompasses the C...
Imugene and Kincell Bio Enter Strategic Partnership for Manufacturing and Process Development
Wednesday, April 17, 2024Imugene Ltd and Kincell Bio LLC have announced a strategic partnership focusing on manufacturing and process development The agreement involves Imugene selling its Current Good Manufacturing
